- Home
- MRK vs ABT Comparison
MRK vs ABT Comparison
Compare MRK & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- ABT
- Stock Information
- Founded
- MRK 2000
- ABT 1888
- Country
- MRK United States
- ABT United States
- Employees
- MRK N/A
- ABT N/A
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- ABT Medical/Dental Instruments
- Sector
- MRK Health Care
- ABT Health Care
- Exchange
- MRK Nasdaq
- ABT Nasdaq
- Market Cap
- MRK 218.8B
- ABT 231.5B
- IPO Year
- MRK N/A
- ABT N/A
- Fundamental
- Price
- MRK $91.49
- ABT $128.97
- Analyst Decision
- MRK Buy
- ABT Strong Buy
- Analyst Count
- MRK 15
- ABT 18
- Target Price
- MRK $105.29
- ABT $146.61
- AVG Volume (30 Days)
- MRK 10.7M
- ABT 5.6M
- Earning Date
- MRK 10-30-2025
- ABT 10-15-2025
- Dividend Yield
- MRK 3.56%
- ABT 1.83%
- EPS Growth
- MRK 58.08
- ABT 141.97
- EPS
- MRK 7.56
- ABT 7.96
- Revenue
- MRK $64,235,000,000.00
- ABT $43,843,000,000.00
- Revenue This Year
- MRK $1.82
- ABT $7.55
- Revenue Next Year
- MRK $5.10
- ABT $7.70
- P/E Ratio
- MRK $12.04
- ABT $16.18
- Revenue Growth
- MRK 1.68
- ABT 6.37
- 52 Week Low
- MRK $73.31
- ABT $110.86
- 52 Week High
- MRK $105.07
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- MRK 67.81
- ABT 54.51
- Support Level
- MRK $82.01
- ABT $124.55
- Resistance Level
- MRK $88.30
- ABT $126.62
- Average True Range (ATR)
- MRK 2.18
- ABT 2.12
- MACD
- MRK 0.47
- ABT 0.51
- Stochastic Oscillator
- MRK 87.57
- ABT 98.80
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.